October 15, 2020 — Professors Ouchi (Hamamatsu University) and Suzuki (Hokkaido University) were 2020 Catalyst Awardees of the Healthy Longevity Global Competition held by the U.S. National Academy of Medicine. The PassPort® System was an integral part of their research project titled: "Development of a Novel Alzheimer's Disease Treatment Method by a Unique Brain Protein-derived Peptide with an Advanced Transdermal Absorption Device".
May 14, 2020 -- Research of Professor Yukitoshi Nagahara will be conducted in collaboration with the Clinical Research, Innovation and Education Center at Tohoku University Hospital (CRIETO) in Japan
April 1, 2020 -- Expectations for early clinical application of revolutionary anticancer drugs from Tokyo University of Science using a novel delivery technology
November 18, 2019 -- PassPort Technologies was featured in a recent article published by Nikkei Business Daily. The interview was conducted with PassPort's COO, Dr. Hirotoshi Adachi -- 点滴や錠剤を「貼り薬OKに」 米企業が新投与技術
October 18, 2019 -- Expecting early clinical application of ground-breaking drug discovery innovation generated by Hokkaido University and administered by new drug delivery technology (PassPort® System)
October 1, 2019 -- PassPort Technologies and Axcelead Drug Discovery Partners:
July 1, 2019 -- Nitto Denko Corporation and the Drug Discovery Gateway Investment Limited Partnership operated by Whiz Partners Inc. entered an alliance to accelerate the commercialization of the PassPort® System, an innovative transdermal therapeutic system.